114
Views
29
CrossRef citations to date
0
Altmetric
Original Research

Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells

, , , , , & show all
Pages 2537-2554 | Published online: 31 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Mona Alibolandi, Khalil Abnous, Sajjad Anvari, Marzieh Mohammadi, Mohammad Ramezani & Seyed Mohammad Taghdisi. (2018) CD133-targeted delivery of self-assembled PEGylated carboxymethylcellulose-SN38 nanoparticles to colorectal cancer. Artificial Cells, Nanomedicine, and Biotechnology 46:sup1, pages 1159-1169.
Read now
Zahra Daman, Homa Faghihi & Hamed Montazeri. (2018) Salinomycin nanoparticles interfere with tumor cell growth and the tumor microenvironment in an orthotopic model of pancreatic cancer. Drug Development and Industrial Pharmacy 44:9, pages 1434-1442.
Read now
Md. Habban Akhter, Md. Rizwanullah, Javed Ahmad, Mohamed Jawed Ahsan, Md. Ali Mujtaba & Saima Amin. (2018) Nanocarriers in advanced drug targeting: setting novel paradigm in cancer therapeutics. Artificial Cells, Nanomedicine, and Biotechnology 46:5, pages 873-884.
Read now
Shupei Qiao, Yufang Zhao, Shuai Geng, Yong Li, Xiaolu Hou, Yi Liu, Feng-Huei Lin, Lifen Yao & Weiming Tian. (2016) A novel double-targeted nondrug delivery system for targeting cancer stem cells. International Journal of Nanomedicine 11, pages 6667-6678.
Read now
In-Sun Hong, Gyu-Beom Jang, Hwa-Yong Lee & Jeong-Seok Nam. (2015) Targeting cancer stem cells by using the nanoparticles. International Journal of Nanomedicine 10:sup1, pages 251-260.
Read now

Articles from other publishers (24)

Anastasiya N. Shishparenok, Vitalina V. Furman & Dmitry D. Zhdanov. (2023) DNA-Based Nanomaterials as Drug Delivery Platforms for Increasing the Effect of Drugs in Tumors. Cancers 15:7, pages 2151.
Crossref
Yulin Chen, Xianmin Wu, Jiadong Li, Yingying Jiang, Ke Xu & Jiacan Su. (2022) Bone-Targeted Nanoparticle Drug Delivery System: An Emerging Strategy for Bone-Related Disease. Frontiers in Pharmacology 13.
Crossref
Elham Poonaki, Ann-Christin Nickel, Mehdi Shafiee Ardestani, Lars Rademacher, Marilyn Kaul, Evgeny Apartsin, Sven G. Meuth, Ali Gorji, Christoph Janiak & Ulf Dietrich Kahlert. (2022) CD133-Functionalized Gold Nanoparticles as a Carrier Platform for Telaglenastat (CB-839) against Tumor Stem Cells. International Journal of Molecular Sciences 23:10, pages 5479.
Crossref
Maha Ali Alghamdi, Antonino N. Fallica, Nicola Virzì, Prashant Kesharwani, Valeria Pittalà & Khaled Greish. (2022) The Promise of Nanotechnology in Personalized Medicine. Journal of Personalized Medicine 12:5, pages 673.
Crossref
Mazen M. El-Hammadi & José L. Arias. (2022) Recent Advances in the Surface Functionalization of PLGA-Based Nanomedicines. Nanomaterials 12:3, pages 354.
Crossref
Xiong Shu, Weifeng Liu, Huiqi Liu, Hui Qi, Chengai Wu & Yu-Liang Ran. (2021) Analysis of microRNA expression in CD133 positive cancer stem‑like cells of human osteosarcoma cell line MG-63. PeerJ 9, pages e12115.
Crossref
Lucia Ruxandra Tefas, Cristina Barbălată, Cristian Tefas & Ioan Tomuță. (2021) Salinomycin-Based Drug Delivery Systems: Overcoming the Hurdles in Cancer Therapy. Pharmaceutics 13:8, pages 1120.
Crossref
Noelia Nieto González, Antonella Obinu, Giovanna Rassu, Paolo Giunchedi & Elisabetta Gavini. (2021) Polymeric and Lipid Nanoparticles: Which Applications in Pediatrics?. Pharmaceutics 13:5, pages 670.
Crossref
Zhaoying Fu & Jim Xiang. (2020) Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy. International Journal of Molecular Sciences 21:23, pages 9123.
Crossref
Gayathri Ravichandran & Aravind Kumar Rengan. (2020) Aptamer-Mediated Nanotheranostics for Cancer Treatment: A Review. ACS Applied Nano Materials 3:10, pages 9542-9559.
Crossref
Carla Garcia-Mazas, Sheila Barrios-Esteban, Noemi Csaba & Marcos Garcia-Fuentes. 2020. Biomaterials for Cancer Therapeutics. Biomaterials for Cancer Therapeutics 365 398 .
Dong-Min Kim, Minhee Kim, Hee-Bin Park, Keun-Sik Kim & Dong-Eun Kim. (2019) Anti-MUC1/CD44 Dual-Aptamer-Conjugated Liposomes for Cotargeting Breast Cancer Cells and Cancer Stem Cells. ACS Applied Bio Materials 2:10, pages 4622-4633.
Crossref
Alice Turdo, Veronica Veschi, Miriam Gaggianesi, Aurora Chinnici, Paola Bianca, Matilde Todaro & Giorgio Stassi. (2019) Meeting the Challenge of Targeting Cancer Stem Cells. Frontiers in Cell and Developmental Biology 7.
Crossref
Danielle E. Large, Jonathan R. Soucy, Jacob Hebert & Debra T. Auguste. (2019) Advances in Receptor-Mediated, Tumor-Targeted Drug Delivery. Advanced Therapeutics 2:1, pages 1800091.
Crossref
Mao Ye, Santosh K. Misra, Arun K. De, Fatemeh Ostadhossein, Kuldeep Singh, Laurie Rund, Lawrence Schook & Dipanjan Pan. (2018) Design, Synthesis, and Characterization of Globular Orphan Nuclear Receptor Regulator with Biological Activity in Soft Tissue Sarcoma. Journal of Medicinal Chemistry 61:23, pages 10739-10752.
Crossref
Carlos Rodríguez-Nogales, Yolanda González-Fernández, Azucena Aldaz, Patrick Couvreur & María J. Blanco-Prieto. (2018) Nanomedicines for Pediatric Cancers. ACS Nano 12:8, pages 7482-7496.
Crossref
Fan Yang, Xi Wen, Qin-Fei Ke, Xue-Tao Xie & Ya-Ping Guo. (2018) pH-responsive mesoporous ZSM-5 zeolites/chitosan core-shell nanodisks loaded with doxorubicin against osteosarcoma. Materials Science and Engineering: C 85, pages 142-153.
Crossref
Tomoyuki Okumura, Hirohumi Kojima, Tetsuji Yamaguchi & Yutaka Shimada. 2018. Molecular Diagnosis and Targeting for Thoracic and Gastrointestinal Malignancy. Molecular Diagnosis and Targeting for Thoracic and Gastrointestinal Malignancy 49 62 .
Binbin Li, Qinghua Li, Jingxin Mo & Honglian Dai. (2017) Drug-Loaded Polymeric Nanoparticles for Cancer Stem Cell Targeting. Frontiers in Pharmacology 8.
Crossref
Weiwei Qin, Guan Huang, Zuanguang Chen & Yuanqing Zhang. (2017) Nanomaterials in Targeting Cancer Stem Cells for Cancer Therapy. Frontiers in Pharmacology 8.
Crossref
Bing Lu, Xiaojia Huang, Jingxin Mo & Wei Zhao. (2016) Drug Delivery Using Nanoparticles for Cancer Stem-Like Cell Targeting. Frontiers in Pharmacology 7.
Crossref
Ander Abarrategi, Juan Tornin, Lucia Martinez-Cruzado, Ashley Hamilton, Enrique Martinez-Campos, Juan P. Rodrigo, M. Victoria González, Nicola Baldini, Javier Garcia-Castro & Rene Rodriguez. (2016) Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies. Stem Cells International 2016, pages 1-13.
Crossref
Tomohiro Fujiwara & Toshifumi Ozaki. (2016) Overcoming Therapeutic Resistance of Bone Sarcomas: Overview of the Molecular Mechanisms and Therapeutic Targets for Bone Sarcoma Stem Cells. Stem Cells International 2016, pages 1-13.
Crossref
A Borah, S Raveendran, A Rochani, T Maekawa & D S Kumar. (2015) Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy. Oncogenesis 4:11, pages e177-e177.
Crossref